{"schema_version":"secwatch.filing_event.v1","accession":"0001562762-23-000269","form_type":"8-K","ticker":"GMED","cik":"0001237831","company_name":"GLOBUS MEDICAL INC","filed_at":"2023-06-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:38.203601+00:00","generated_at":"2026-06-14T04:44:47.492409+00:00","sec_items":["5.02","5.07","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"Globus Medical stockholders elect directors, approve equity plan amendment, ratify auditor, approve say-on-pay","bullets":["Daniel T. Scavilla elected with 249.4M votes for, 34.2M withheld; Robert A. Douglas with 281.5M for.","Amendment to 2021 Equity Incentive Plan approved: 229.9M for, 53.7M against, 58.7K abstain.","Deloitte & Touche LLP ratified as auditor for FY2023: 289.5M for, 144K against.","Non-binding advisory vote on executive compensation approved: 278.8M for, 4.9M against."],"urls":{"canonical":"https://secwatch.observer/filing/0001562762-23-000269","json":"https://secwatch.observer/filing/0001562762-23-000269.json","markdown":"https://secwatch.observer/filing/0001562762-23-000269.md","text":"https://secwatch.observer/filing/0001562762-23-000269.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1237831/000156276223000269/0001562762-23-000269-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1237831/000156276223000269/gmed-20230607x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-14T04:44:47.492409+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"58dfec0df349b7677cb6d76cdcc40c21bfdd32ec","claim":"GLOBUS MEDICAL INC shareholders approved Ratification of the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023 at the 2023-06-07 meeting.","evidence_excerpt":"Proposal 3 Ratification of the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023. This proposal was approved. For Against Abstain Broker Non-Vote 289,461,330 144,307 30,698 0","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1237831/000156276223000269/0001562762-23-000269-index.htm","confidence":1.0,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"auditor ratification"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-06-07"}],"fact_type":"shareholder_vote"},{"claim_id":"710a24e25c14c183907a2b65498de9f40382265b","claim":"GLOBUS MEDICAL INC shareholders approved Non-binding advisory vote to approve the compensation of the Company’s named executive officers at the 2023-06-07 meeting.","evidence_excerpt":"Proposal 4 A non-binding advisory vote to approve the compensation of the Company’s named executive officers, as described in the Company’s definitive proxy statement on Schedule 14A filed with the Securities and Exchange Commission. This proposal was approved. For Against Abstain Broker Non-Vote 278,760,964 4,855,821 81,727 5,937,823","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1237831/000156276223000269/0001562762-23-000269-index.htm","confidence":1.0,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"say on pay"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-06-07"}],"fact_type":"shareholder_vote"},{"claim_id":"ac496961b990f43ca410bddec74c75dc95873657","claim":"GLOBUS MEDICAL INC shareholders approved Election of Directors at the 2023-06-07 meeting.","evidence_excerpt":"Proposal 1 The individuals listed below were each elected at the Annual Meeting to serve a three-year term on the Company’s Board of Directors. Nominee For Withhold Broker Non-Vote Daniel T. Scavilla 249,448,775 34,249,737 5,937,823 Robert A. Douglas 281,453,058 2,245,454 5,937,823","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1237831/000156276223000269/0001562762-23-000269-index.htm","confidence":1.0,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"director election"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-06-07"}],"fact_type":"shareholder_vote"},{"claim_id":"af523716b75e44711e57542ff015173eb6b8c299","claim":"GLOBUS MEDICAL INC shareholders approved Approval of the Amendment to the 2021 Equity Incentive Plan at the 2023-06-07 meeting.","evidence_excerpt":"Proposal 2 Approval of the Amendment to the 2021 Equity Incentive Plan: For Against Abstain Broker Non-Vote 229,917,089 53,722,734 58,689 5,937,823","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1237831/000156276223000269/0001562762-23-000269-index.htm","confidence":1.0,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"equity plan"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-06-07"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}